| 骨肉瘤内科治疗研究进展：ASCO会议（2007）展望 |
| |
| 引用本文： | 林丽珠,刘清华,周岱翰.骨肉瘤内科治疗研究进展：ASCO会议（2007）展望[J].癌症进展,2008,6(1):47-52. |
| |
| 作者姓名： | 林丽珠 刘清华 周岱翰 |
| |
| 作者单位： | 广州中医药大学,第一临床医学院,第一附属医院肿瘤治疗中心,广州,510407 |
| |
| 摘 要： | 骨肉瘤是一种起源于间叶组织的恶性肿瘤，是骨骼系统最常见的恶性肿瘤，多发于青少年。手术、放化疗对骨肉瘤的疗效仍然有限，新辅助化疗、生物靶向治疗、免疫疗法及中医中药已成为骨肉瘤治疗新的发展方向，但骨肉瘤治疗研究仍有待新的突破。2007年ASCO会议报告了有关骨肉瘤治疗最新研究进展，本文结合目前国内外研究对骨肉瘤的内科治疗现状作一浅要综述。
|
| 关 键 词： | 骨肉瘤 化疗 靶向治疗 |
Progression in osteosarcoma under medical treatment:Highlights in ASCO 2007 |
| |
| Lin Lizhu,Liu Qinghua,Zhou Daihan.Progression in osteosarcoma under medical treatment:Highlights in ASCO 2007[J].Oncology Progress,2008,6(1):47-52. |
| |
| Authors: | Lin Lizhu Liu Qinghua Zhou Daihan |
| |
| Institution: | Lin Lizhu, Liu Qinghua, Zhou Daihan(Department of Tumor, NO. 1 Affiliated Hospital, Guangzhou Traditional Medicine University, Guangzhou 510407, China) |
| |
| Abstract: | Osteosarcoma,derived from mesenchymal tissue,is the most frequent malignant tumor in skeletal system.It is the third most common malignancy in children and adolescents.Up to now,limited curative effects are achieved in operation,chemotherapy and radiotherapy in the treat- ment of osteosarcoma.Prospective therapeutic effects have been confirmed in new therapies including neoadjuvant chemotherapy,bio-targeted therapy,immunotherapy,and traditional Chinese medicine, although further breakthrough is still on the way.We summarize the recent advances in osteosarcoma treatment along with highlights reported in ASCO 2007. |
| |
| Keywords: | osteosarcoma chemotherapy targeted therapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
